In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS's flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. Without Congressional action, more…
In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS's flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. Without Congressional action, more cuts will begin on January 1, 2025. ACLA urges Congress to enact long-term PAMA reform to protect access to quality laboratory diagnostics and services.
-
ACLA Welcomes PAMA Relief in Funding Package, Urges Congress to Advance RESULTS Act in 2026
Washington, D.C. — The American Clinical Laboratory Association (ACLA) today welcomed bipartisan congressional action to temporarily delay Medicare payment cuts to clinical laboratory testing, helping ... Read More -
ACLA Statement on Pending Congressional Action on PAMA
Washington, D.C. — The House on January 22, 2026, passed a bipartisan spending bill that would provide urgently needed relief from further reductions to the Medicare ... Read More -
ACLA Urges Swift Congressional Action on Bipartisan RESULTS Act Following Energy & Commerce Hearing
Washington, D.C. — The American Clinical Laboratory Association (ACLA) today urged swift congressional action to advance the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing ... Read More -
ACLA Written Testimony: Legislative Proposals to Support Patient Access to Medicare Services
-
ACLA Recognizes 30 Leading Patient and Consumer Organizations for Supporting RESULTS Act to Protect Access to Clinical Laboratory Testing
Washington, D.C. — The American Clinical Laboratory Association (ACLA) recognizes the 30 patient and consumer advocacy organizations representing millions of Americans who recently called on ... Read More -
Letter from Leading Patient and Consumer Groups on Passing the RESULTS Act
-
ACLA Applauds Enactment of Short-Term PAMA Relief in Spending Package and Urges Advancement of RESULTS Act
Washington, D.C. – The American Clinical Laboratory Association (ACLA) applauds the enactment of a short-term delay to payment cuts to the Medicare Clinical Laboratory Fee Schedule ... Read More -
New Analysis Shows Clinical Laboratories Contribute $140 Billion Annually to the Economy, Supporting Nearly 670,000 Jobs Nationwide
Repeated Medicare Cuts Could Weaken Laboratory Infrastructure, Limit Patient Access to Timely Laboratory Services, and Hinder Investment in Next-Generation Diagnostic Tests Washington, D.C. – The American ... Read More -
ACLA and 30+ Leading Provider Organizations Urge Congress to Pass RESULTS Act to Protect Access to Clinical Laboratory Services
Without Congressional action in 2025, cuts threaten patient access to timely, innovative clinical laboratory tests Washington, D.C. – The American Clinical Laboratory Association (ACLA) joined ... Read More -
Letter from Leading Provider Groups on Passing the RESULTS Act
